Literature DB >> 11270004

A comparison of remifentanil and fentanyl in patients undergoing carotid endarterectomy.

P W Doyle1, J P Coles, T M Leary, P Brazier, A K Gupta.   

Abstract

BACKGROUND AND AIM: We investigated the haemodynamic stability and emergence characteristics of isoflurane/nitrous oxide anaesthesia supplemented with remifentanil or fentanyl in patients undergoing carotid endarterectomy.
METHODS: Anaesthesia was induced with propofol (1-2 mg kg-1) and either remifentanil (0.5 microgram kg-1) or fentanyl (1 microgram kg-1), followed by an infusion of remifentanil (0.2 microgram kg-1 min-1) or fentanyl (2 micrograms kg-1 h-1).
RESULTS: There were no significant differences between the groups in haemodynamic variables, postoperative pain, nausea or vomiting. After induction there was a significant decrease in mean arterial pressure for both groups (P < 0.001) and a decrease in heart rate (P = 0.001) in the remifentanil group. In both groups these haemodynamic changes continued during maintenance of anaesthesia (P < 0.05). The time to eye opening after surgery was significantly shorter with remifentanil compared with fentanyl (6.62 +/- 3.89 vs. 18.0 +/- 15.18 min, P = 0.015).
CONCLUSION: Remifentanil appears to be a comparable opioid to fentanyl when supplementing isoflurane/nitrous oxide anaesthesia for carotid endarterectomy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11270004     DOI: 10.1046/j.1365-2346.2001.00763.x

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  3 in total

Review 1.  [Anesthesia for carotid artery surgery. Is there a gold standard?].

Authors:  T Rössel; R J Litz; A R Heller; T Koch
Journal:  Anaesthesist       Date:  2008-02       Impact factor: 1.041

2.  Postoperative pain scores and analgesic requirements after thyroid surgery: comparison of three intraoperative opioid regimens.

Authors:  C Motamed; J C Merle; L Yakhou; X Combes; J Vodinh; C Kouyoumoudjian; P Duvaldestin
Journal:  Int J Med Sci       Date:  2006-01-01       Impact factor: 3.738

Review 3.  Remifentanil update: clinical science and utility.

Authors:  Richard Beers; Enrico Camporesi
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.